Evidence map›Paper›PMID 22423967›Full record

ArticleCell host & microbe2012

The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity.

Chul-Su Yang, Mary Rodgers, Chan-Ki Min, Jong-Soo Lee, Lara Kingeter, June-Yong Lee, Ambrose Jong, Igor Kramnik, Xin Lin, Jae U Jung

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. ENKD1 attenuates antibacterial immunity by facilitating TRIM21-mediated RUBCN degradation to suppress LC3-associated phagocytosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of autophagy in viral infections.Journal of biomedical science · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Chul-Su YangDepartment of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033, USA.
Mary Rodgers
Chan-Ki Min
Jong-Soo Lee
Lara Kingeter
June-Yong Lee
Ambrose Jong
Igor Kramnik
Xin Lin
Jae U Jung
University of Southern California · USThe University of Texas MD Anderson Cancer Center · USBoston University · USChildren's Hospital of Los Angeles · US

Funding

TRIM mediated host antiviral responses during influenza virus infectionsU19AI083025 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2009 to 2013
$10.0M
ORF36 Viral Kinase as a Transcriptional Regulator of KSHVP01DE019085 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2008 to 2012
$6.4M
Molecular Basis of KSHV PathogenesisR01CA082057 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 1999 to 2016
$5.1M
MOLECULAR BASIS FOR HERPESVIRUS SAIMIRI ONCOGENICITYR01CA031363 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 1985 to 2014
$4.9M
Role of viral BCI-2 mediated anti-apoptosis and-autophagyR01AI073099 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2007 to 2017
$4.3M
KSHV RTA: more than viral replicationR01CA115284 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2005 to 2015
$3.1M
When Autophagy Meets PhagocytosisR01HL110609 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2011 to 2015
$2.0M
Cell growth deregulation by KSHV protein.R01CA106156 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2004 to 2008
$1.5M
A novel immune evasion strategy of KSHV K3 and K5R01CA091819 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JUNG, JAE U · 2001 to 2005
$1.5M
Herpesvirus saimiri TIPR01CA109697 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2005 to 2009
$1.5M
STUDY OF KSHV REACTIVATION AND PATHOGENESISR01CA086841 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JUNG, JAE U · 2000 to 2003
$1.1M
NCI NIH HHS CA115284NCI NIH HHS CA31363NCI NIH HHS CA82057NCI NIH HHS R01 CA031363NCI NIH HHS R01 CA082057NCI NIH HHS R01 CA086841NCI NIH HHS R01 CA091819NCI NIH HHS R01 CA106156NCI NIH HHS R01 CA109697NCI NIH HHS R01 CA115284NHLBI NIH HHS HL110609NHLBI NIH HHS R01 HL110609NIAID NIH HHS AI073099NIAID NIH HHS AI083025NIAID NIH HHS R01 AI073099NIAID NIH HHS U19 AI083025NIDCR NIH HHS DE019085NIDCR NIH HHS P01 DE019085
6 · The paper itself

Abstract

Assembly of a scaffold consisting of CARD9, BCL10, and MALT1 (CBM complex) is critical for effective signaling by multiple pattern recognition receptors (PRRs) including Dectin and RIG-I. The RUN domain Beclin-1-interacting cysteine-rich-containing Rubicon protein associates constitutively with the Beclin-UVRAG-Vps34 complex under normal conditions to regulate autophagy. Rubicon also interacts with the phagocytic NADPH-oxidase complex upon TLR stimulation to induce potent antimicrobial responses. Here, we show Rubicon is a physiological feedback inhibitor of CBM-mediated PRR signaling, preventing unbalanced proinflammatory responses. Upon Dectin-1- or RIG-I-mediated activation, Rubicon dynamically exchanges binding partners from 14-3-3β to CARD9 in a stimulation-specific and phosphorylation-dependent manner, disassembling the CBM signaling complex and ultimately terminating PRR-induced cytokine production. Remarkably, Rubicon's actions in the autophagy complex, phagocytosis complex, and CBM complex are functionally and genetically separable. Rubicon thus differentially targets signaling complexes, depending on environmental stimuli, and may function to coordinate various immune responses against microbial infection.

Indexed as

Immunity, Innate14-3-3 ProteinsAdaptor Proteins, Signal TransducingAnimalsAutophagy-Related ProteinsB-Cell CLL-Lymphoma 10 ProteinBinding, CompetitiveCandida albicansCandidiasisCARD Signaling Adaptor ProteinsCaspasesCells, CulturedCytokinesFeedback, PhysiologicalHost-Pathogen InteractionsHumans14-3-3 ProteinsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsB-Cell CLL-Lymphoma 10 ProteinBCL10 protein, humanCARD9 protein, humanCARD Signaling Adaptor ProteinsCaspasesCytokinesIntracellular Signaling Peptides and ProteinsMALT1 protein, humanMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinMultiprotein ComplexesNeoplasm ProteinsRUBCN protein, humanYWHAB protein, human

Identifiers

PMID22423967
PMCPMC3615900
OpenAlexW1987625474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.